Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-20

FDA Approved: GANIRELIX ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ganirelix Acetate submitted by Meitheal Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganirelix acetate (ganirelix acetate)

Snippet

SUPPL AP for GANIRELIX ACETATE (GANIRELIX ACETATE)